1374672-84-0Relevant articles and documents
Copper(I) Complexes Bearing 1,2-Phenyl-Bridged P∧N, P∧N∧P, and N∧P∧N Chelate Ligands: Structures and Phosphorescence
Zeng, Chao,Wang, Nan,Peng, Tai,Wang, Suning
, p. 1616 - 1625 (2017)
With the aim to obtain new phosphorescent Cu(I) compounds, several new 1,2-phenyl-bridged P∧N, P∧N∧P, and N∧P∧N chelate ligands were designed and synthesized. These ligands were found to form complexes with Cu(I) ion readily via either solution reactions or solid-state grinding process. The new Cu(I) compounds based on this class of ligands display phosphorescence with emission color ranging from blue to red. The structure of the ligand and the nature of the N-heterocycle in the chelate ligands were found to have a significant impact on the phosphorescent properties of the Cu(I) compounds.
A PHENYL TRIAZOLE DERIVATIVE AND ITS USE FOR MODULATING THE GABAA RECEPTOR COMPLEX
-
Page/Page column 14; 15, (2014/01/17)
This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous s
TRIAZOLE DERIVATIVES AND THEIR USE FOR NEUROLOGICAL DISORDERS
-
Page/Page column 40, (2012/05/31)
The present invention is concerned with novel triazole compounds of formula (I) wherein A, X, Y, Z, R1, R2, and R3 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. The active compounds of present invention have affinity and selectivity for the GABA A α5 receptor. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.